Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Heat-based back pain procedures denied Medicare coverage

This article was originally published in The Gray Sheet

Executive Summary

CMS issues national non-coverage determination for thermal intradiscal procedures to treat low back pain Sept. 29 after determining that they are "not reasonable and necessary" based on available evidence. A proposal to deny Medicare coverage for the catheter-based treatment was announced in July (1"The Gray Sheet" July 21, 2008, p. 6). Intradiscal electrothermal therapy system maker Smith & Nephew (SpineCath) says it will "continue to work with CMS and support an immediate request for reconsideration." Baylis Medical says it hopes to submit to CMS by September 2009 results of an ongoing study of its TransDiscal disc biacuplasty system that would differentiate it for reimbursement purposes

You may also be interested in...

Medicare Proposal Pours Cold Water On Heat-Based Back Pain Therapy

CMS may nationally deny coverage of thermal intradiscal procedures to treat low back pain based on lack of clear benefit, the agency said July 15

Trump Pushes Back On OIG Report That Hospitals Want Feds To Better Police Resources, Relax Regs

When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.

Execs On The Move: Promotions Are In The Spotlight At Terumo And MiMedx Group

Japanese medical device manufacturer Terumo Corp. promoted senior management execs; MiMedx Group, developer of human placental tissue allografts, raised exec to CFO; and more.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts